Your browser doesn't support javascript.
loading
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study.
Sandborn, William J; Danese, Silvio; Leszczyszyn, Jaroslaw; Romatowski, Jacek; Altintas, Engin; Peeva, Elena; Hassan-Zahraee, Mina; Vincent, Michael S; Reddy, Padmalatha S; Banfield, Christopher; Salganik, Mikhail; Banerjee, Anindita; Gale, Jeremy D; Hung, Kenneth E.
Afiliación
  • Sandborn WJ; University of California San Diego, La Jolla, California. Electronic address: wsandborn@health.ucsd.edu.
  • Danese S; Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
  • Leszczyszyn J; Melita Medical, Gastroenterology, Wroclaw, Poland.
  • Romatowski J; Provincial Complex Hospital, Gastroenterology, Bialystok, Poland.
  • Altintas E; Mersin University, Gastroenterology, Mersin, Turkey.
  • Peeva E; Pfizer Global Research and Development, Cambridge, Massachusetts.
  • Hassan-Zahraee M; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Vincent MS; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Reddy PS; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Banfield C; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Salganik M; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Banerjee A; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Gale JD; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
  • Hung KE; Pfizer Inc, Early Clinical Development, Cambridge, Massachusetts.
Clin Gastroenterol Hepatol ; 21(10): 2616-2628.e7, 2023 09.
Article en En | MEDLINE | ID: mdl-36623678

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article